Drug Trial Radar · NCT01421498
Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)
Last checked: Nov 20, 2026Latest source record: Jun 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
588
Actual
Start
Aug 29, 2011
Primary completion
Apr 28, 2012
Study completion Apr 28, 2012
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Aug 22, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the efficacy of SAR 1118 Ophthalmic Solution (5.0%) compared to placebo in the treatment of Dry Eye. The safety and tolerability of SAR 1118 Ophthalmic Solution (5.0%) compared to placebo in subjects with dry eye when administered BID for 12 weeks will also be evaluated.
Conditions
- Keratoconjunctivitis Sicca
- Dry Eye Disease
Interventions
LifitegrastDrug
Dosage Form: Ophthalmic Solution Dosage: 5.0% Frequency: BID Duration: 12 weeks
PlaceboDrug
Dosage Form: Ophthalmic Solution Frequency: BID Duration: 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ocular Sign: Change From Baseline in Inferior Corneal Fluorescein Staining to Day 84Time frame: Baseline (Day 0) to Day 84
- Ocular Symptom: Change From Baseline in Visual-Related Subscale of the Symptom Functional Scale Score to Day 84Time frame: Baseline (Day 0) to Day 84
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
OPUS-1 Investigational Site
Waterbury, Connecticut
OPUS-1 Investigational Site
Louisville, Kentucky
OPUS-1 Investigational Site
Augusta, Maine
OPUS-1 Investigational Site
Lewiston, Maine
OPUS-1 Investigational Site
Andover, Massachusetts
OPUS-1 Investigational Site
Lancaster, Massachusetts
OPUS-1 Investigational Site
Quincy, Massachusetts
OPUS-1 Investigational Site
Wakefield, Massachusetts
OPUS-1 Investigational Site
Winchester, Massachusetts
OPUS-1 Investigational Site
Derry, New Hampshire
OPUS-1 Investigational Site
Manchester, New Hampshire
OPUS-1 Investigational Site
Memphis, Tennessee
OPUS-1 Investigational Site
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.